Bristol-Myers Squibb Co (WBO:BMYS) Common Stock : €269 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bristol-Myers Squibb Co Common Stock?

Bristol-Myers Squibb Co's quarterly common stock declined from Sep. 2023 (€274 Mil) to Dec. 2023 (€268 Mil) but then increased from Dec. 2023 (€268 Mil) to Mar. 2024 (€269 Mil).

Bristol-Myers Squibb Co's annual common stock increased from Dec. 2021 (€258 Mil) to Dec. 2022 (€276 Mil) but then declined from Dec. 2022 (€276 Mil) to Dec. 2023 (€268 Mil).

Bristol-Myers Squibb Co Common Stock Historical Data

The historical data trend for Bristol-Myers Squibb Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Common Stock Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

262.80

240.02

258.42

275.65

267.76

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															272.73	269.52	273.60	267.76	268.64

Bristol-Myers Squibb Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Bristol-Myers Squibb Co (WBO:BMYS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (WBO:BMYS) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (WBO:BMYS) Headlines

No Headlines